Read more pharma stories on Newserhttp://www.newser.com/taggrid/2221/pharma.html2010 - Newseren-usNewser Feed Generator2010-03-11T23:34:28http://www.newser.com/story/81805/mccain-slams-obama-for-backroom-deals.htmlWhen John McCain finally got a chance to speak at the health care summit today, he let Barack Obama have it, slamming him for crafting the legislation with backroom deals. In particular, he hit on the deal the White House struck with Big Pharma, in which Obama promised to block...http://www.newser.com/story/81805/mccain-slams-obama-for-backroom-deals.html2010-02-25T17:52:07http://www.newser.com/story/71879/dems-helped-shape-health-industry-ad-campaign.htmlAides to President Obama and Max Baucus met with a variety of lobbyists for corporate health care companies on April 15, to help form two industry coalitions and launch a multimillion-dollar ad campaign, Politico has learned. Though both sides insist no quid pro quo was laid out, some participants say...http://www.newser.com/story/71879/dems-helped-shape-health-industry-ad-campaign.html2009-10-16T16:19:01http://www.newser.com/story/66132/pharma-ghostwriters-penned-medical-papers-on-hrt.htmlGhostwriters funded by a drug firm were deeply involved in writing papers supporting therapies that helped the firm’s sales boom, court papers show. The 26 scientific papers, published in medical journals from 1998 to 2005, highlighted the benefits of hormone replacement therapy over the risks, a boon to Wyeth, which...http://www.newser.com/story/66132/pharma-ghostwriters-penned-medical-papers-on-hrt.html2009-08-05T12:20:00http://www.newser.com/story/62404/obama-big-pharma-heres-an-80b-drug-discount.htmlBig Pharma has offered the feds a discount of up to $80 billion on drugs for programs like Medicare, the Washington Post reports. The pledge, which comes at a crucial moment in the health-reform debate, may be a pre-emptive strike before President Obama pushes for a proposed $100 billion price...http://www.newser.com/story/62404/obama-big-pharma-heres-an-80b-drug-discount.html2009-06-20T21:41:06http://www.newser.com/story/30348/big-pharma-sickens-universities.htmlWeak legislation allows professors to collect huge under-the-table payments from Big Pharma, and it’s time to fight back, Dan Greenberg writes in the Chronicle of Higher Education . Pharmaceutical companies pay professors to shill drugs and lend their names to industry research, and the only oversight is an honor-system mechanism requiring...http://www.newser.com/story/30348/big-pharma-sickens-universities.html2008-06-22T23:07:27http://www.newser.com/story/5508/generics-curb-rise-in-drug-costs.htmlScores of prescription drugs are getting cheaper, as name-brand patents expire and open the door to generic imitators. That's bad news for pharmaceutical companies, the Times reports, but it means that an aging population ever more reliant on drugs will be paying as much as 80 percent less for them.http://www.newser.com/story/5508/generics-curb-rise-in-drug-costs.html2007-08-08T23:37:49http://www.newser.com/story/5377/grocery-chain-offers-free-rx-meds.htmlPharmacies in Publix supermarkets across five Southern states will distribute seven antibiotics free to patients with prescriptions, the chain said today. The CEO allows that one goal is to drive customer traffic, but it's also an example of the private sector assisting access to affordable health care, the AP reports....http://www.newser.com/story/5377/grocery-chain-offers-free-rx-meds.html2007-08-06T20:17:09http://www.newser.com/story/2831/nigeria-sues-pfizer-over-deadly-tests.htmlNigeria is suing pharma giant Pfizer for $7 billion, claiming the company carried out improper trials on children. 200 children in the state of Kano died, and others developed deformities, after Pfizer tested Trovan, an experimental antibiotic, during a 1996 meningitis outbreak. Nigeria claims the tests were unauthorized, but Pfizer...http://www.newser.com/story/2831/nigeria-sues-pfizer-over-deadly-tests.html2007-06-05T17:35:06http://www.newser.com/story/2676/glaxo-stems-stock-slide-over-avandia.htmlGlaxo shares pulled out of a tailspin after the pharma giant defended its second biggest selling drug, Avandia, against claims that it triggers heart attacks. A sharply worded letter from the company's chief medical officer on the website of medical journal The Lancet pointed out that the increased incidence of...http://www.newser.com/story/2676/glaxo-stems-stock-slide-over-avandia.html2007-05-31T11:44:02